BioSpace News Archive

Genetown

Werewolf Therapeutics to Participate in May Investor Conferences

Werewolf Therapeutics, Inc. today announced that management will participate at the following conferences in the month of May.

May 1, 2023
·
1 min read
Business

Alladapt Appoints Louise Peacock as Chief Regulatory Affairs and Quality Officer

Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company developing prescription therapeutics to address IgE-mediated food allergy, announced the appointment of Louise Peacock as Chief Regulatory Affairs and Quality Officer, effective May 1, 2023.

May 1, 2023
·
3 min read
Pharm Country

Axsome Therapeutics Joins Mental Health America and the State of New York to Raise Awareness of Mental Health During May is Mental Health Month

Axsome Therapeutics, Inc. is joining Mental Health America (MHA) and the State of New York to raise awareness of mental health during May is Mental Health Month.

May 1, 2023
·
7 min read
FDA

Cabaletta Bio Receives FDA Fast Track Designation for CABA-201

Cabaletta Bio, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for CABA-201, a 4-1BB-containing fully human CD19-CAR T cell investigational therapy.

May 1, 2023
·
8 min read
Business

Syndax to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 8, 2023

Syndax Pharmaceuticals, Inc. today announced that it will report its first quarter 2023 financial results and provide a business update on Monday, May 8, after the close of the U.S. financial markets.

May 1, 2023
·
1 min read
Genetown

Verastem Oncology to Participate in Upcoming Investor Conferences

Verastem Oncology today announced that the Company will participate in the following upcoming investor conferences.

May 1, 2023
·
1 min read
Genetown

AlloVir to Present at the BofA Securities 2023 Health Care Conference

AlloVir, Inc. announced today that Diana Brainard, M.D., Chief Executive Officer, will participate in a fireside chat at the BofA Securities 2023 Health Care Conference in Las Vegas, NV on Tuesday, May 9, 2023, at 8:40 a.m. PDT.

May 1, 2023
·
1 min read
Pharm Country

Bristol Myers Squibb’s TRANSCEND FL and TRANSCEND NHL 001 Studies of Breyanzi in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma Meet Primary Endpoint of Overall Response Rate

Bristol Myers Squibb’s TRANSCEND FL and TRANSCEND NHL 001 Studies of Breyanzi (lisocabtagene maraleucel) in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma Meet Primary Endpoint of Overall Response Rate.

May 1, 2023
·
17 min read
Business

Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights

Envision Pharma Group (Envision) has appointed Tino Quintero to the role of General Manager/VP of Market Access & Customer Insights.

May 1, 2023
·
2 min read
Pharm Country

Anavex Life Sciences Announces Issuance of New U.S. Patent Expanding ANAVEX®2-73 (blarcamesine) Intellectual Property Portfolio for the Treatment of Hypertension

Anavex Life Sciences Corp. announced today it was granted a new U.S. Patent No. 11,622,955 entitled “SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY,” from the United States Patent and Trademark Office.

May 1, 2023
·
5 min read